Trial ID 17160 | Maryland Oncology Hematology Trial ID 17160 – Maryland Oncology Hematology

Trial ID 17160

Trial Information - Phase III

PANOVA-3: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma

Protocol ID: EF-27

Sponsor: Covance/Novocure

Status: OPEN TO ENROLLMENT

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Pancreas

Investigator

Narang MD, Mohit

Status

OPEN TO ENROLLMENT

Sponsor

Covance/Novocure

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology